Set forth below is a discussion of the financial condition and results of operations for the Group for the nine month period ending September 30, 2003. This discussion should be read in conjunction with the unaudited Consolidated Financial Statements and Notes for the nine month period ended September 30, 2003 included herein.
Set forth below is a discussion of turnover for each of our principal businesses.
Electronic Materials’ turnover decreased from £48.2 million for the nine months ended September 30, 2002 to £45.1 million for the nine months ended September 30, 2003, a decrease of 6.5%. Electronic Materials’ turnover decreased from £19.3 million for the three months ended September 30, 2002 to £15.9 million for the three months ended September 30, 2003, a decrease of 17.7%, Electronic Materials’ sales have decreased mainly due to lower customer demand for ink jet printing consumables and adverse exchange effects.
Fine Chemicals’ turnover decreased from £119.4 million for the nine months ended September 30, 2002 to £91.4 million for the nine months ended September 30, 2003, a decrease of 23.4%. Fine Chemicals’ turnover decreased from £39.9 million for the three months ended September 30, 2002 to £24.1 million for the three months ended September 30, 2003, a decrease of 39.7%. Fine Chemicals turnover has decreased due to a decline in demand for pharmaceutical custom large-scale manufacturing, lower manufacture of DNA medicines caused by preparations for GMP validation and manufacture, and the disposal of the Intermediates & Stabilizers business.
Specialty Products’ turnover decreased from £124.5 million for the nine months ended September 30, 2002 to £102.4 million for the nine months ended September 30, 2003, a decrease of 17.7%. Specialty Products’ turnover decreased from £37.7 million for the three months ended September 30, 2002 to £30.3 million for the three months ended September 30, 2003, a decrease of 19.5%. Specialty Products’ turnover decrease is mainly due to the exit from the Pigments business at the end of 2002 and from the Metal Extraction business in July 2003, combined with adverse exchange effects.
NeoResins’ turnover increased from £130.0 million for the nine months ended September 30, 2002, to £134.9 million for the nine months ended September 30, 2003, an increase of 3.7%. NeoResins’ turnover increased from £43.4 million for the three months ended September 30, 2002, to £44.6 million for the three months ended September 30, 2003, an increase of 2.9%. NeoResins’ increase in turnover reflects positive exchange rate impacts combined with increased customer demand for adhesive and graphics arts products from customers in the Americas.
Back to Contents
Avecia Group plc
Management’s Discussion and Analysis of Financial Conditions and Results of Operations – (continued)
Operating costs
Operating costs increased from £416.9 million for the nine months ended September 30, 2002 to £421.3 million for the nine months ended September 30, 2003. This increase reflects impairment charges taken against goodwill and fixed assets totalling £39.5 million in the three months to June 30, 2003, offset by reductions caused by the exit from the Pigments business in 2002. Operating costs decreased from £138.0 million for the three months ended September 30, 2002 to £115.3 million for the three months ended September 30, 2003. This decrease mainly reflects the exit from the Pigments business in 2002 and the Metal Extraction Products and Intermediates & Stabilizers businesses in 2003. In addition operating costs reductions arose from the voluntary severance programme commenced at the end of 2002.
Operating profit / (loss)
Total operating results decreased from £15.8 million profit for the nine months ended September 30, 2002 to £36.2 million loss for the nine months ended September 30, 2003. Total operating results decreased from £5.5 million profit for the three months ended September 30, 2002 to £3.7 million profit for the three months ended September 30, 2003.
Electronic Materials’ operating results increased from £1.0 million profit in the nine months ended September 30, 2002, to £2.5 million profit for the nine months ended September 30, 2003. Electronic Materials’ operating results decreased from £3.0 million profit in the three months ended September 30, 2002, to £2.0 million profit for the three months ended September 30, 2003. The change in profits was mainly due to the reduced sales noted above offset by reduced costs of goods sold due to lower materials prices and improved efficiency.
Fine Chemicals’ operating results decreased from a loss of £4.3 million for the nine months ended September 30, 2002, to a loss of £46.3 million for the nine months ended September 30, 2003 mainly due to an impairment charge taken against fixed assets, combined with the reduced sales noted above. Fine Chemicals’ operating results decreased from a loss of £2.6 million for the three months ended September 30, 2002, to a loss of £6.3 million for the three months ended September 30, 2003 mainly due to the reduced sales noted above.
Specialty Products’ operating profit decreased from a profit of £24.5 million for the nine months ended September 30, 2002 to a profit of £20.2 million for the nine months ended September 30, 2003. Specialty Products’ operating profit decreased from £7.6 million profit for the three months ended September 30, 2002 to £5.0 million profit for the three months ended September 30, 2003. The decrease in operating profits was mainly due to the reduced sales noted above and adverse exchange rates.
NeoResins’ operating profit decreased from a profit of £23.2 million for the nine months ended September 30, 2002 to £22.6 million for the nine months ended September 30, 2003, with the increased sales noted above offset by increases in raw material and shipping costs. NeoResins’ operating profit increased from £6.9 million for the three months ended September 30, 2002 to £8.2 million for the three months ended September 30, 2003, reflecting the increased sales noted above combined with close control of costs.
Central costs, including goodwill amortisation, increased from £29.5 million for the nine months ended September 30, 2002 to £35.6 million for the nine months ended September 30, 2003, due to additional amortisation of goodwill of £12.5 million.
Back to Contents
Avecia Group plc
Management’s Discussion and Analysis of Financial Conditions and Results of Operations – (continued)
Share of operating profit from joint ventures
Our pro-rata share of the earnings from both of our Image Polymers joint ventures decreased from £2.0 million for the nine months ended September 30, 2002, to £1.4 million for the nine months ended September 30, 2003. Our pro-rata share of the earnings from both of our Image Polymers joint ventures decreased from £0.5 million for the three months ended September 30, 2002, to £0.4 million for the three months ended September 30, 2003.
Exceptional Items
On July 31, 2003 Avecia sold the Metal Extraction Products (MEP) and Intermediates & Stabilizers (I&S) businesses to Cytec Industries Inc. The initial consideration receivable was US$97 million in cash. Under the agreement, Cytec acquired substantially all of the assets and liabilities of thebusinesses including the majority of assets at Avecia’s Mount Pleasant site, Tennessee. The MEP business formed part of the Specialty Products portfolio and the I&S business formed part of the Fine Chemicals segment. Net proceeds from the sale of these businesses were used primarily to repay a portion of the Senior Secured Credit Facility. Avecia is continuing to pursue asset sales where appropriate prices can be obtained for specific businesses, and may dispose of business segments in the future. At the present time no agreements have been reached on the disposal of any further businesses or assets.
Profit on ordinary activities before interest and tax
The net profit decreased from £26.5 million profit for the nine months ended September 30, 2002 to £20.6 million loss for the nine months ended September 30, 2003. The net profit increased from £4.2 million for the three months ended September 30, 2002 to £18.2 million for the three months ended September 30, 2003.
Net interest
Net interest expense for the nine months to September 30, 2003 was £33.8 million, compared to a net expense of £24.2 million for the nine months to September 30, 2002. Net interest expense for the three months to September 30, 2003 was £14.6 million, compared to a net expense of £6.5 million for the three months to September 30, 2002. After allowing for the effects of unrealized exchange differences and reduced fee amortisation, there is a decrease in net interest expense as a result of lower bank debt, repayments having been made.
Taxation
The charge for taxation for the nine months to September 30, 2003 was £2.3 million against a charge of £4.1 million for taxation in the nine months to September 30, 2002. The charge for taxation for the three months to September 30, 2003 was £1.0 million against a charge of £0.9 million for the three months to September 30, 2002.
Liquidity and capital resources
Cash generated from operations totalled £37.6 million inflow for the nine months to September 30, 2003 compared to £65.1 million inflow for the nine months to September 30, 2002. Operating income plus depreciation and amortization was £52.1 million in the nine months to September 30, 2003 compared to £69.7 million in the nine months to September 30, 2002. Working capital outflows in the nine months to September 30, 2003 were £15.6 million compared to outflows of £4.8 million in the nine months to September 30, 2002.
Back to Contents
Avecia Group plc
Management’s Discussion and Analysis of Financial Conditions and Results of Operations – (continued)
The Group’s net cash requirement for servicing debt in the nine months of operation ended September 30, 2003 was £42.9 million comprising interest income of £0.8 million and interest paid of £43.7 million. The Group’s net cash requirement for servicing debt in the three months of operation ended September 30, 2003 was £18.7 million.
Cash capital expenditure in the nine months to September 30, 2003 was £39.3 million compared with a total of £30.7 million in the nine months to September 30, 2002, with the increase reflecting the construction of the new Advanced Biologics Centre in the UK.
In the nine months to September 30, 2003 the cash outflow for taxation was £0.2 million. In the nine months to September 30, 2002 the cash outflow for taxation was £2.8 million. In the three months to September 30, 2003 the cash outflow for taxation was £0.2 million. In the three months to September 30, 2002 the cash outflow for taxation was £1.3 million.
In the nine months to September 30, 2003 the Group made payments of £1.9 million in respect of the acquisition of subsidiaries. This represents the deferred amounts due as part of the purchase of Covion.
In the nine months to September 30, 2003 the Group received £79.6 million relating to the disposal of subsidiaries. This comprised the deferred proceeds from the disposal of the Stahl business, completed in January 2002, as well as the consideration for the disposal of the Metal Extraction and Intermediates and Stabilisers businesses discussed above.
In total, the above factors contributed to a net decrease in cash in the nine months to September 30, 2003 of £12.6 million. For the nine months to September 30, 2002 the net decrease in cash was £7.7 million.
At September 30, 2003 the group had outstanding external borrowings of £532.7 million, gross of capitalised issue costs, comprising £325.5 million of 11% Senior Notes due 2009, £108.9 million of Senior Secured Credit Facility repayable in semi-annual instalments between 2003 and 2006 (Term Loan A), £38.8 million of Senior Secured Credit Facility repayable in 2007 (Term Loan B), £37.5 million of Senior Secured Credit Facility repayable in 2008 (Term Loan C). Of the £100 million Senior Secured Revolving Credit, available until 2006, £2.0 million has been utilized as at September 30, 2003 to provide guarantee facilities, and £16.5 million has been utilized as at September 30, 2003 to provide overdraft facilities. As at September 30, 2003 £22.0 million of the remaining facility has been utilized.
The group is required to make scheduled principal repayments of approximately £15 million on the Senior Debt in December 2003, and further prepayments of £30 million during 2004.
The principal sources of funds continues to be the cash flows generated from operating activities and utilization of the undrawn Senior Secured Revolving Credit Facility and overdraft facilities discussed above, currently amounting to £76 million.
The Senior Secured Credit Facility requires the Group to operate within certain financial ratios, including: |
| |
(i) | a ratio of Consolidated EBITDA to Consolidated Net Interest Charges (as defined in the Credit Agreement) |
(ii) | a ratio of Adjusted Cash Flow to Relevant Expenditure (as defined in the Credit Agreement) |
(iii) | a ratio of Net Senior Debt to Consolidated EBITDA (as defined in the Credit Agreement) |
(iv) | a maximum limitation on capital expenditure in each financial year. |
Back to Contents
Avecia Group plc
Management’s Discussion and Analysis of Financial Conditions and Results of Operations – (continued)
These ratios are tested periodically (quarterly, half-yearly, or annually depending on each covenant) and compliance confirmed to the lenders under the Senior Secured Credit Facility. The limits applicable to the financial ratios for each period were set out in the original Credit Agreement and are varied from time to time with the formal agreement of the lenders under the Senior Secured Credit Facility. Avecia has not breached these financial ratio limits as at September 30, 2003.
Avecia’s ability to comply with these financial ratios in the future will depend on its operating performance and level of indebtedness. Avecia may not be able to maintain compliance with the financial ratios under the Senior Secured Credit Facility on 31 December 2003 and it intends to enter promptly into discussions with the lenders under the Facility to ensure that the Credit Facility agreement is amended or appropriate waivers obtained if these are required.
Back to Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Avecia Group plc |
| | |
Date: November 25, 2003 | By: | /s/: Derrick Nicholson |
| Name: | Derrick Nicholson |
| Title: | Finance Director |